Results showed that the expression level of BCL11A was higher in most cancers compared with normal tissues, such as cholangiocarcinoma, colon adenocarcinoma, esophageal carcinoma, lung cancer, kidney cancer, and so on (Fig. 1A). This evidence concerns the gene BCL11A and colon adenocarcinoma.